A practical regiospecific synthesis of 9-nitrocamptothecin

被引:3
|
作者
Fu, QingQuan
Chen, Zhiyong
机构
[1] Chinese Acad Sci, Chengdu Inst Organ Chem, Key Lab Asymmet Synth & Chirotechnol Sichuan Prov, Chengdu 610041, Peoples R China
[2] Chinese Acad Sci, Chengdu Inst Organ Chem, Union Lab Asymmetr Synth, Chengdu 610041, Peoples R China
[3] Chinese Acad Sci, Grad Sch, Beijing 10049, Peoples R China
来源
SYNTHESIS-STUTTGART | 2006年 / 12期
关键词
9-nitrocamptothecin; nitration; reduction of sulfonate;
D O I
10.1055/s-2006-942359
中图分类号
O62 [有机化学];
学科分类号
070303 ; 081704 ;
摘要
9-Nitrocamptothecin has shown potent antitumor activity against many types of human cancers. A practical scale-up procedure for this compound is reported by selective reduction of corresponding sulfonate.
引用
收藏
页码:1940 / 1942
页数:3
相关论文
共 50 条
  • [1] 抗癌新药9-Nitrocamptothecin
    郑震寰
    郑珩
    药学进展, 2001, (05) : 310 - 311
  • [2] Rubitecan -: 9-Nitrocamptothecin -: Camptogen® -: Oncolytic
    不详
    DRUGS OF THE FUTURE, 2001, 26 (12) : 1216 - 1217
  • [3] Enhanced cytogenetic and antitumor effects by 9-nitrocamptothecin and antineoplastics
    Karaberis, E
    Mourelatos, D
    TERATOGENESIS CARCINOGENESIS AND MUTAGENESIS, 2000, 20 (03): : 141 - 146
  • [4] Alkyl esters of camptothecin and 9-nitrocamptothecin: Synthesis, in vitro pharmacokinetics, toxicity, and antitumor activity
    Cao, ZS
    Harris, N
    Kozielski, A
    Vardeman, D
    Stehlin, JS
    Giovanella, B
    JOURNAL OF MEDICINAL CHEMISTRY, 1998, 41 (01) : 31 - 37
  • [5] FDA grants orphan drug status to 9-nitrocamptothecin
    不详
    BIOTECHNOLOGY LAW REPORT, 1996, 15 (06): : 916 - 916
  • [6] 9-nitrocamptothecin liposome aerosol: Lack of subacute toxicity in dogs
    Gilbert, BE
    Seryshev, A
    Knight, V
    Brayton, C
    INHALATION TOXICOLOGY, 2002, 14 (02) : 185 - 197
  • [7] Effect of phospholipid composition on characterization of liposomes containing 9-nitrocamptothecin
    Chen, J
    Ping, QN
    Guo, JX
    Chu, XZ
    Song, MM
    DRUG DEVELOPMENT AND INDUSTRIAL PHARMACY, 2006, 32 (06) : 719 - 726
  • [8] Structure-activity relationship of alkyl 9-nitrocamptothecin esters
    Cao, ZS
    Pantazis, P
    Mendoza, J
    Early, J
    Kozielski, A
    Harris, N
    Giovanella, B
    ACTA PHARMACOLOGICA SINICA, 2003, 24 (02) : 109 - 119
  • [9] Pharmacology study of multiple oral doses of 9-nitrocamptothecin (9NC)
    Verschraegen, CF
    Harris, N
    Steger, M
    Kavanagh, JJ
    Kudelka, AP
    Giovanella, B
    Gupta, E
    ANNALS OF ONCOLOGY, 1998, 9 : 70 - 70
  • [10] Antitumor efficacy, toxicity and pharmacokinetics of 9-nitrocamptothecin: role of lactone ratio
    Chen, Jun
    Hu, Rong-Rong
    Yang, Xi-Xiong
    Gu, Wei
    Tian, Rong
    Gong, Fang
    Luo, Lei
    Fang, Fang
    Chen, Zhi-Peng
    Cai, Bao-Chang
    CANCER CHEMOTHERAPY AND PHARMACOLOGY, 2013, 72 (04) : 925 - 929